Self‐monitoring of blood pressure (SMBP) improves blood pressure (BP) outcomes at 12‐months, but information is lacking on how SMBP affects hypertension care processes and longer‐term BP outcomes.

We pooled individual participant data from 4 randomized clinical trials of SMBP in the United Kingdom (combined n=2590) with varying intensities of support. Multivariable random effects regression was used to estimate the probability of antihypertensive intensification at 12 months for usual care versus SMBP. Using these data, we simulated 5‐year BP control rates using a validated mathematical model. Trial participants were mostly older adults (mean age 66.6 years, SD 9.5), male (53.9%), and predominantly white (95.6%); mean baseline BP was 151.8/85.0 mm Hg. Compared with usual care, the likelihood of antihypertensive intensification increased with both SMBP with feedback to patient or provider alone (odds ratio 1.8, 95% CI 1.2–2.6) and with telemonitoring or self‐management (3.3, 2.5–4.2). Over 5 years, we estimated 33.4% BP control (<140/90 mm Hg) with usual care (95% uncertainty interval 27.7%–39.4%). One year of SMBP with feedback to patient or provider alone achieved 33.9% (28.3%–40.3%) BP control and SMBP with telemonitoring or self‐management 39.0% (33.1%–45.2%) over 5 years. If SMBP interventions and associated BP control processes were extended to 5 years, BP control increased to 52.4% (45.4%–59.8 %) and 72.1% (66.5%–77.6%), respectively.

One year of SMBP plus telemonitoring or self‐management increases the likelihood of antihypertensive intensification and could improve BP control rates at 5 years; continuing SMBP for 5 years could further improve BP control.